Abbvie Layoffs 2025. The company has been working on al002 with abbvie since the two entered a partnership in 2017. A worker adjustment and retraining notification reports that abbvie is culling 178 jobs from stemcentrx, a biotech it spent $5.8 billion on, with.

Revenue down 5% in 2023 from 2022. The company has been working on al002 with abbvie since the two entered a partnership in 2017.